Orphanet: Clinical trials
x

Search for a clinical trial

* (*) mandatory field

Other search option(s)

PARCT: Phase II Trial of Atezolizumab (Anti-PD-L1) in the Treatment of Stage IIb-IV Mycosis Fungoides/Sezary Syndrome Patients Relapsed/Refractory After a Previous Systemic Treatment -ES (completed)

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funded by an IRDiRC member
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Eortc
  • Website
    • Phase : II

Download document

  • Principal investigator of clinical trial

  • INFORMATION NOT PROVIDED
  • Institution: Information not provided - ES
  • ADDRESS: NOT PROVIDED - ES
  • SPAIN
  • More information
  • Phone  : 
    Information not provided - ES
  • Fax  : -

  • Sponsor of clinical trial

  • EORTC
  • European Organisation for the Research and Treatment of Cancer
  • EORTC
  • Avenue Mounierlaan 83/11
  • 1200 BRUSSELS
  • BELGIUM
  • More information
  • Phone  : 0032 2 7741611
  • Fax  : 0032 2 7723545
  • Website
Last update: October 2022

Part of a multinational clinical trial

BELGIUM

BRUSSELS

EORTC

More Information

Additional information

Further information on this research

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.